Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: UNIVERSITY OF OKLAHOMA
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-16 to 2025-11-15
Current total value of award: $1113527
Description: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM, TASK ORDER TITLE: A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER